HyreCar Inc. (HYRE) Accused of Materially Misstating its Insurance Reserves     A class action was filed on behalf of all persons and entities that purchased or otherwise acquired HyreCar Inc.

Annovis Bio, Inc. (ANVS) Materially Misrepresented the Outcome of its ANVS401 Clinical Trials According to a class action complaint filed on behalf of Annovis Bio, Inc. shareholders, between May 21,

Tencent Music Entertainment Group (TME) Shareholders Harmed When Goldman Sachs Group and Morgan Stanley Sold Shares    A Tencent Music Entertainment Group (NYSE: TMR) shareholder filed a class action on

Amarin Corporation plc (AMNR) Misled the Investing Public Regarding the Impact Pending Patent Litigation Would Have on the Company’s Future Prospects   A shareholder filed a class action on behalf

Höegh LNG Partners LP (HMLP) Misled the Investing Public Regarding its Business Prospects    A shareholder filed a class action on behalf of all persons and entities that purchased or

BioMarin Pharmaceutical Inc. (BMRN) Misled the Investing Public Regarding the Safety of its Product Candidate BMN 307 A shareholder filed a class action on behalf of all persons and entities

CarLotz, Inc. (LOTZ, LOTZW) Accused of Making False and Misleading Statements Regarding its Business, Operations, and Prospects   CarLotz became a public entity via merger with Acamar Partners Acquisition Corp.,

Cassava Sciences, Inc. (SAVA) Accused of Falsely Touting the Viability and Efficacy of its Lead Drug Candidate     A class action was filed on behalf of all persons and entities that

Amarin Corporation plc (AMNR) Misled the Investing Public Regarding the Impact Pending Patent Litigation Would Have on the Company’s Future Prospects   A shareholder filed a class action on behalf